Latest Breaking News On - Yazhou wang - Page 1 : comparemela.com

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer, and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.

Yazhou wangMedicinal chemistryInsilico medicineArtificial intelligenceBreast cancerDrug discoveryMedicinal chemistryOmen 39s health